Markets:

Overview

News

Currencies

International

Treasuries

MorphoSys AG - American Depositary Shares (NQ:MOR)

18.96 UNCHANGED

Last Price Updated: 4:00 PM EDT, Aug 2, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about MorphoSys AG - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >

Morpheus Launches $20 Million In Rewards For AI Compute Providers ↗

December 11, 2024

Morpheus, a decentralized platform for deploying AI-driven “Smart Agents,” has launched a $20 million reward program for compute providers.

Via Benzinga

Topics Artificial Intelligence

3 Global Stocks to Buy to Escape the Volatility on Wall Street ↗

July 16, 2024

Discover three top global stocks as a smart hedge against Wall Street volatility, offering diversification and resilience in uncertain times.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

May 27, 2024

Via Benzinga

MOR Stock Earnings: MorphoSys Misses EPS, Misses Revenue for Q1 2024 ↗

April 30, 2024

MOR stock results show that MorphoSys missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Via InvestorPlace

MorphoSys Says Novartis Deal Progressing Steadily Despite Safety Concerns Over Bone Marrow Cancer Drug, Pelabresib ↗

April 29, 2024

MorphoSys faces safety concerns over pelabresib, a myelofibrosis treatment. Physicians report patients transitioning rapidly to acute myeloid leukemia. FDA alerted. Novartis acquisition proceeds...

Via Benzinga

MorphoSys: Q4 Earnings Insights ↗

March 13, 2024

Via Benzinga

Earnings Outlook For MorphoSys ↗

March 12, 2024

Via Benzinga

Dow Plummets on Rising Bond Yields, MCD Earnings ↗

February 05, 2024

Via Talk Markets

Topics Stocks

Incyte Should Consider Significant Stock Buyback And Prioritize R&D, Analyst Recommends ↗

April 23, 2024

Incyte acquires Escient Pharmaceuticals for $750 million, bolstering its pipeline. Cantor Fitzgerald initiates coverage with a Neutral rating, citing undervaluation concerns despite strong cash flow.

Via Benzinga

Earnings Scheduled For March 13, 2024 ↗

March 13, 2024

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.

Via Benzinga

5 Biotechnology Stocks To Buy For A Stable Portfolio In 2024 ↗

March 09, 2024

Things have been looking better for the biotech industry in 2024 after a decent performance in 2023. Here is a look at some biotech stocks that may provide stability to one's portfolio throughout the...

Via Talk Markets

3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise ↗

March 07, 2024

Discover the pivotal roles of cancer-fighting biotech stocks that are advancing cancer research and subsequently, their financial growth.

Via InvestorPlace

Exit Now! 3 Biotech Stocks to Sell in February 2024 ↗

February 21, 2024

These biotech stocks to sell represent incredibly risky bets, amidst the sector's volatility and looming economic unpredictability.

Via InvestorPlace

Novartis Agrees To Acquire German Blood Cancer-Drug Developer MorphoSys For €2.7B ↗

February 06, 2024

Novartis' €2.7 billion public takeover offer for MorphoSys, unlocking a promising oncology pipeline with pelabresib and tulmimetostat.

Via Benzinga

Biotech Stock MorphoSys Catapults 56% As Novartis Agrees To Buy It For $2.9 Billion ↗

February 05, 2024

Novartis will add to its cancer treatment pipeline with via the German biotech.

Via Investor's Business Daily

Why Is MorphoSys (MOR) Stock Up 50% Today? ↗

February 05, 2024

News of a potential takeout bid for any company usually leads to a big surge. That's what investors are seeing today with MOR stock.

Via InvestorPlace

Why Air Products and Chemicals Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

February 05, 2024

Shares of Air Products and Chemicals, Inc. (NYSE: APD) fell sharply during Monday’s session after the company reported worse-than-expected first-quarter financial results and lowered FY24 adjusted EPS...

Via Benzinga

MorphoSys Stock Soars After Report Says Novartis To Acquire Cancer-Drug Developer ↗

February 05, 2024

Novartis is in advanced talks to acquire MorphoSys and appears to be beating out Incyte Corporation which has also made an offer to acquire MorphoSys. MorphoSys produces a lymphoma drug, Monjuvi, sold...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

February 05, 2024

Via Benzinga

Estée Lauder Posts Upbeat Earnings, Joins ON Semiconductor, Tyson Foods And Other Big Stocks Moving Higher On Monday ↗

February 05, 2024

U.S. stocks traded lower, with the Dow Jones falling over 300 points on Monday.

Via Benzinga

Topics Stocks

Philips Reports Q4 Results, Joins Ryanair And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

January 29, 2024

U.S. stock futures were mixed this morning, with the Dow futures falling around 50 points on Monday.

Via Benzinga

Topics Stocks

Why Super Micro Computer Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket ↗

January 19, 2024

Shares of Super Micro Computer, Inc. (NASDAQ: SMCI) rose sharply in pre-market trading after the company announced updated financial guidance for the second-quarter, which surpassed its previou

Via Benzinga

Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 19, 2024

Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share. TransCode...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 19, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

January 19, 2024

We're starting the final day of trading this week with a look at the biggest pre-market stock movers for Friday morning!

Via InvestorPlace

iRobot, AST SpaceMobile And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

January 19, 2024

U.S. stock futures were higher this morning, with the Nasdaq futures gaining over 100 points on Friday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 16, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 16, 2024

Via Benzinga

Why LQR House Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket ↗

January 16, 2024

Shares of LQR House Inc. (NASDAQ: LQR) rose sharply in pre-market trading. Borg's investor group has acquired a 20% stake in LQR House. LQR House shares jumped 16.1% to $4.25 in pre-market trading Here...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

January 16, 2024

We're starting off Tuesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on this morning!

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.